InvestorsHub Logo
Followers 272
Posts 12274
Boards Moderated 0
Alias Born 04/05/2007

Re: TheKobra post# 942

Thursday, 01/07/2016 8:32:44 AM

Thursday, January 07, 2016 8:32:44 AM

Post# of 1047
Looking good for today.....from latest 8K

Exhibit 99.1 is a press release issued by Eiger on January 6, 2016 entitled “Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 LOWR HDV – 4 (LOnafarnib With Ritonavir in Hepatitis Delta Virus – 4) Study at Hannover Medical School in Hannover, Germany.”



http://ih.advfn.com/p.php?pid=nmona&article=69912725&symbol=CLDN

Moving right along to human trials now.

CLDN

HPT

Disclaimer: The views expressed by me are solely those of the author and should not be construed as reason to buy or sell any security I mention. Always do your own DD(due diligence), I have.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EIGRQ News